Sernova Biotherapeutics Announces $13 Million Debt-to-Equity Conversion Eliminating Significant Financing Overhang Oct 1, 2025 07:00AM
Sinovac Biotech (SVA) Announces Appointment of New CEO Aug 12, 2024 07:50AM